Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses

Markets Associated Press

Celgene Corp. to pay $280 million to settle lawsuit alleging it promoted cancer drugs for unapproved uses.

Continue Reading Below